Latest News
From the Journals
T-DM1 produces 44% response rate in HER2-mutant lung cancers
Confirmed partial responses were seen in 44% of patients with HER2-mutant metastatic lung adenocarcinomas enrolled in a phase 2, investigator-...
From the Journals
IVF linked to slight increase in risk of some cancers
A large observational study found no increase in risk for uterine cancer, but small increases in risk of some breast and ovarian cancers in women...
From the Journals
Early BCC seen in teen kidney transplant patient
Conference Coverage
Ibrutinib/venetoclax shows early promise in relapsed CLL
STOCKHOLM – An ongoing study shows a high clinical response rate and acceptable safety profile with the chemotherapy-free targeted therapy...
Feature
What might Kavanaugh confirmation mean for ACA, abortion access?
Judge Brett M. Kavanaugh was nominated to the Supreme Court by President Trump on July 9.
News from the FDA/CDC
FDA gives green light to freeze-dried plasma in combat
Although the FDA is still working to approve the product for general use, it authorized its use in combat-related emergency situations.
From the Journals
Recombinant poliovirus appears safe, active as recurrent glioblastoma treatment
The survival data in a phase 1 study of 61 patients showed a plateau, with a 36-month survival rate of 21%, compared with 4% for a historical...
From the Journals
ABP 980 similar to trastuzumab in HER2+ breast cancer in all but name
The LILAC trial comparing ABP 980 to trastuzumab missed its primary endpoint, but the biosimilar outperformed the reference drug in efficacy.
Latest News
CMS holds ACA risk adjustment payments following legal ruling
The CMS filed a motion to reconsider following the New Mexico verdict, a hearing of which was held June 21.
From the Journals
Oral arsenic/ATRA is noninferior to IV form in APML
The oral formulation offers a convenient alternative for treating non–high-risk acute promyelocytic leukemia.
From the Journals
Intensive nonaspirin NSAID use linked to reduced ovarian cancer mortality
Intensive use of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with improved survival of patients with serous ovarian...